Revogliform 2/0.3 Tablet SR
Marketer
Dr.Revmax Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Revogliform 2/0.3 Tablet SR
Combiflora 2/0.3 Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer Combiflora 2/0.3 ER Tablets with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle modifications are key to successful diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling (edema), blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to assess blood cell counts and liver function.
Uses of Revogliform 2/0.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Revogliform 2/0.3 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Revogliform 2/0.3 Tablet SR on an empty stomach.
Common Side effects of Revogliform 2/0.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Revogliform 2/0.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Revogliform 2/0.3 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Revogliform 2/0.3 Tablet SR works:
Revogliform SR tablets (2mg/0.3mg) contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Revogliform 2/0.3 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Revogliform 2/0.3 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Revogliform 2/0.3mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Revogliform 2/0.3 Tablet SR due to potential safety concerns. Medical advice is recommended. The use of Revogliform 2/0.3 Tablet SR is contraindicated in those with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Revogliform 2/0.3 Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. A reduced initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Revogliform 2/0.3 Tablet SR :
Should you forget to take a Revogliform 2/0.3 Tablet SR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Revogliform 2/0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently